GoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide. GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced it is working with Sanofi (NASDAQ: SNY), a global leader in diabetes care, to offer a new way for people living with diabetes to access Lantus® (insulin...
All of them my wishes. There are not advice . Chose your decision good luck
GDRX heading to <$20. From there should start reversal. Based on quarterly result may do some consolidation. Would take ~6-9 months to reclaim $40. If interested look out for an entry around ~$18.
The WAE hit the explosion line, you can see the other times it hit this line and what happened. The Vortex5 Seems to be curling up. The RSI7 is curling up.
$DGRX looks really nice here *Broke out from that $40 level and pulled to put in a successful test *Putting in nice trading range with supply line around $44 *volume pattern looks healthy *couple pause days here would be PERFECT (orange bars)
GoodRx Holdings, Inc. (GDRX) Sector: Technology Services (Internet Software/Services) Current Price: $43.97 Breakout price trigger: $45.40 Buy Zone (Top/Bottom Range): $42.60-$37.40 Price Target: $49.00-$50.00 (1st), $55.00-$56.00 (2nd) Estimated Duration to Target: 23-25d (1st), 72-76d (2nd) Contract of Interest: $GDRX 11/19/21 45c, $GDRX 12/17/21 50c Trade...
GDRX delivered earnings better than expected. Today it moved up very confident,it hold gains. Volume is 3 times average, this is a very good sign Looking for continuation several days more
lets go watch em pump it watch em sell it off at earnings
NASDAQ:GDRX bullish crossover about to happen. Entry $38. SL $33.50
Seems good for short term. Just my Analysis; Please check and comment
Loving the setup I am seeing right now for potential short and long positions on GDRX coming into key support market structure around 36.84. Here is my thinking: Strong downtrend since Feb. 11 Downtrend broken with move on March 09/10 Key range resistance established at 43.50 (formerly support) Retracement move to recent and historical support level...
Previous channel was hit perfectly and held as support during the last weeks capitulation. 7MA is strong resistance above. RSI has rejected at previous S/R level. Very risky to hold into earnings, may be a better entry in the weeks to come.
So i have been investing in GDRX since its release in September 2020. They have been flowing between 40's and 50's for a while. I hope this stock can push in the 60s or higher sometime soon. I am committed to this stock i am holding this stock. GDRX is a great entry level healthcare stock for new investors.